RESULTS FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH INTERMEDIATE, OR HIGH RISK, RELAPSED/REFRACTORY MYELOFIBROSIS

EHA Library, Naveen Pemmaraju, 266467

RUXOLITINIB TREATMENT AND RISK OF B-CELL LYMPHOMAS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Chiara Cavalloni, 266468

MOLECULAR CLASSIFICATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA WHO DEVELOP RESISTANCE OR INTOLERANCE TO HYDROXYUREA

EHA Library, Álvaro Díaz González, 266469

RATE OF THROMBOSIS IN CONTEMPORARY PATIENTS WITH POLYCYTHEMIA VERA UNDER HYDROXYUREA REMAINS EXCEEDINGLY HIGH. RESULTS OF SYSTEMATIC REVIEW AND METANALYSIS.

EHA Library, Alberto Ferrari, 266470

RESULTS FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Hassan Alkhateeb, 266471

PHASE 1/2 STUDY OF RUXOLITINIB (RUX) PLUS DECITABINE (DAC) IN PATIENTS (PTS) WITH POST-MYELOPROLIFERATIVE NEOPLASM ACUTE MYELOID LEUKEMIA (POST-MPN AML)

EHA Library, Prithviraj Bose, 266472

OUTCOME OF PATIENTS WITH MYELOFIBROSIS AFTER RUXOLITINIB DISCONTINUATION: ROLE OF DISEASE STATUS AND TREATMENT STRATEGIES IN 218 PATIENTS

EHA Library, Giuseppe Palumbo, 266473

JAK2V617F AND MPL MUTATIONS ARE ASSOCIATED WITH WORSENED SYMPTOM BURDEN THAN CALR IN THE MYELOPROLIFERATIVE NEOPLASMS: FINDINGS FROM THE MYMPN PATIENT REGISTRY

EHA Library, Robyn Scherber, 266474

BODY MASS INDEX AND TOTAL SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASMS - DISCOVERY OF A U-SHAPED ASSOCIATION

EHA Library, Robyn Scherber, 266475

DNA HYPERMETHYLATION EMERGES AS THE STRONGEST PREDICTOR FOR POOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML)

EHA Library, Charlotte Niemeyer, 266476

MOLECULAR PROFILE AND RISK OF THROMBOSIS IN JAK2V617F POLYCYTHEMIA VERA PATIENTS

EHA Library, Anna Angona Figeuras, 266477

REAL-WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG-TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSIS

EHA Library, Fiorenza BARRACO, 266478

MAJOR OR CLINICALLY RELEVANT NON-MAJOR HEMORRHAGIC EVENTS IN A LARGE POPULATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA: LOCALIZATION, CONSEQUENCES AND DRUG USE

EHA Library, Christophe Nicol, 266479

IMPACT OF MYELOPROLIFERATIVE NEOPLASMS (MPNS) AND PERCEPTIONS OF TREATMENT GOALS AMONGST PHYSICIANS AND PATIENTS IN 6 COUNTRIES: AN EXPANSION OF THE MPN LANDMARK SURVEY

EHA Library, Guray Saydam, 266480

MULTICENTER RETROSPECTIVE STUDY EVALUATING FIBROSIS RISK IN PATIENTS WITH ET DEPENDING ON THE TREATMENT SCENARIO

EHA Library, Marta Sobas, 266481

ARTERIAL THROMBOSIS IN YOUNG PV PATIENTS

EHA Library, Giulia Bogoni, 266482

ANAGRELIDE MODULATES PROPLATELET FORMATION RESULTING IN DECREASED NUMBER AND INCREASED SIZE OF PLATELETS

EHA Library, Naohiro Miyashita, 266483

THE RELATIONSHIP BETWEEN TOTAL ANTIOXIDANT CAPACITY AND JAK2V617F MUTATION IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Mihnea-Alexandru Găman, 266484

HEALTHCARE RESOURCE IMPLICATIONS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS AND SPLANCHNIC VEIN THROMBOSIS

EHA Library, Ximena Cabrera Castellano, 266485

RISK OF THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA ACCORDING TO THE JAK2 V617F ALLELE BURDEN

EHA Library, Sung Hwa Bae, 266486

JAK2 ALLELIC RATIO IMPACTS ON VASCULAR EVENT IN MYELOFIBROSIS BY INCREASING THE RISK OF THROMBOSIS. A SINGLE CENTER EXPERIENCE ON 150 PATIENTS.

EHA Library, Mirko Farina, 266487

SAFETY AND EFFICACY OF ROMIPLOSTIM IN OVER 200 CHILDREN WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN AN INTEGRATED DATABASE OF 5 CLINICAL TRIALS

EHA Library, Nichola Cooper, 266488

PREDICTORS OF THERAPY FREE RESPONSES IN ITP PATIENTS RECEIVING TPO-RA. RESULTS FROM A SPANISH MULTICENTER STUDY

EHA Library, Maria L Lozano, 266489

SPLENECTOMY IN IMMUNE THROMBOCYTOPENIA: DO CHANGING TREATMENT PATTERNS FOR ITP AFFECT OUTCOMES? DATA FROM THE UK ITP REGISTRY

EHA Library, Sophie Todd, 266490

COMBINATION OF MYCOPHENOLATE MOFETIL AND DEXAMETHASONE IN THE PATIENTS OF CHRONIC ITP

EHA Library, nilesh wasekar, 266491

PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN THE ELRDELRY AND YOUNGER ADULTS: REAL-WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

EHA Library, Charalampos Pontikoglou, 266492

TREATMENT-FREE REMISSION AFTER TPO RECEPTOR AGONISTS IN ADULT ITP PATIENTS IN BELGIUM

EHA Library, Ann Janssens, 266493

ELTROMBOPAG AS SECOND LINE THERAPY IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ATTEMPT TO TREATMENT-FREE REMISSION. UPDATED RESULTS OF A PHASE II PROSPECTIVE STUDY BY GIMEMA GROUP

EHA Library, Elisa Lucchini, 266494

SAFETY AND EFFICACY OF SELF-ADMINISTERED ROMIPLOSTIM IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP): RESULTS OF AN INTEGRATED ANALYSIS OF FIVE CLINICAL TRIALS

EHA Library, Dominik Selleslag, 266495

LUSUTROMBOPAG IS A SAFE AND EFFICACIOUS TREATMENT OPTION FOR THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING PLANNED INVASIVE PROCEDURES: INTEGRATED ANALYSIS OF TWO PHASE 3 TRIALS

EHA Library, Robert Brown, 266496

LUSUTROMBOPAG RELIABLY INCREASES PLATELETS REGARDLESS OF BASELINE PLATELET COUNTS IN THROMBOCYTOPENIC CHRONIC LIVER DISEASE PATIENTS UNDERGOING PLANNED INVASIVE PROCEDURES: RESULTS OF 2 PHASE 3 TRIALS

EHA Library, Robert Brown, 266497

LUSUTROMBOPAG IS A SAFE TREATMENT OPTION FOR THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING A SCHEDULED INVASIVE PROCEDURE: POOLED SAFETY ANALYSIS FROM 3 STUDIES

EHA Library, Robert Brown, 266498

REAL-WORLD DATA DEMONSTRATE SAFETY AND EFFECTIVENESS OF LUSUTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING PLANNED INVASIVE PROCEDURES: INTERIM ANALYSIS

EHA Library, Fabio De Gregorio, 266499

ASSESSMENT OF ELTROMBOPAG IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA UNDER ROUTINE CLINICAL PRACTICE IN THE MIDDLE EAST, TURKEY, ASIA, AND AUSTRALIA

EHA Library, Raymond S.M. Wong, 266500

USE OF THE THROMBOPOIETIN RECEPTOR AGONIST LUSUTROMBOPAG FOR THROMBOCYTOPENIA IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING PLANNED INVASIVE PROCEDURES: INTEGRATED ANALYSIS OF 2 TRIALS

EHA Library, Naim Alkhouri, 266501

LONG-TERM FOSTAMATINIB TREATMENT OF ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING THE PHASE 3 CLINICAL TRIAL PROGRAM

EHA Library, James Bussel, 266502

CHARACTERISTICS OF PATIENTS WITH CYCLIC THROMBOCYTOPENIA: AN OBSERVATIONAL STUDY

EHA Library, Oskar Steinbrecher, 266503

PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) SHOW IMPAIRED COGNITIVE FUNCTION

EHA Library, Camelia Vladescu, 266504

OCCULT BLEEDING IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: RELATION TO LABORATORY PARAMETERS &ITP HEALTH QUALITY OF LIFE.

EHA Library, AZZA ABDELGAWAD TANTAWY ZAGHLOUL, 266505

INCIDENCE AND OUTCOMES OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN; A SINGLE INSTITUTION EXPERIENCE

EHA Library, Masataka Ito, 266506

THE IMPACT OF ANTIPHOSPHOLIPID ANTIBODIES (APL) ON OUTCOMES OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA AND AUTOIMMUNE HEMOLYTIC ANEMIA TREATED WITH SPLENECTOMY.

EHA Library, Juan Rangel-Patino, 266507

TAPERING AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN ITP: EXPERT CONSENSUS OPINIONS

EHA Library, Nichola Cooper, 266508

LONG-TERM OVERUSE OF CORTICOSTEROIDS IN THE REAL-WORLD TREATMENT OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE US EXPLORYS AND MARKETSCAN DATABASES

EHA Library, James Bussel, 266509

DIFFERENCES IN PERCEPTIONS ON TREATMENT APPROACHES BETWEEN PHYSICIANS AND ITP PATIENTS: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, Alexandra Kruse, 266510

PHYSICIANS’ PERCEPTIONS ON CAUSES OF PRIMARY AND SECONDARY ITP AND LEADING CAUSES OF MISDIAGNOSIS: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, James Bussel, 266511

THERE ARE NO PREDICTIVE FACTORS ASSOCIATED WITH GOOD THERAPY RESPONSE TO SPLENECTOMY FOR PRIMARY IMMUNE THROMBOCYTOPENIA - CONCLUSION BASED ON SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Mirjana Mitrovic, 266512

PATIENT PERCEPTIONS ON SPLENECTOMY OUTCOMES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, Nichola Cooper, 266513

THE IMPACT OF CRIZANLIZUMAB ON VOC-RELATED MEDICAL FACILITY VISITS

EHA Library, Miranda Bailey, 266514

CLINICAL IMPACT OF PROGNOSTIC NUTRITIONAL INDEX IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Gyeong-Won Lee, 266515

QUALITY OF LIFE (QOL), PERSPECTIVES ON TREATMENT AND IMPORTANT OUTCOMES FOR MULTIPLE MYELOMA (MM) PATIENTS AND THEIR CARERS: A MIXED METHODS EVIDENCE SYNTHESIS

EHA Library, Jayne Galinsky, 266516

THE ECONOMIC AND HUMANISTIC BURDEN OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PEDIATRIC PATIENTS: A SYSTEMATIC LITERATURE REVIEW (SLR)

EHA Library, Anna Forsythe, 266517

CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+PTLD WHO FAIL FIRST-LINE RITUXIMAB OR RITUXIMAB PLUS CHEMOTHERAPY: AN ANALYSIS OF GERMAN PTLD REGISTRY

EHA Library, Heiner Zimmermann, 266518

MEDICAL COSTS ASSOCIATED WITH RELAPSE AMONG PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Sheila R. Reddy, 266519

MINIMAL CLINICALLY IMPORTANT DIFFERENCE AND RESPONSIVENESS FOR HM-PRO IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

EHA Library, Pushpendra Goswami, 266520

SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS ONE YEAR AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Simone Oerlemans, 266521

TEN YEARS OF CLINICAL EXPERIENCE WITH BIOSIMILAR FILGRASTIM IN ONCOLOGY AND HAEMATOLOGY

EHA Library, Pere Gascón, 266522

PATIENT CHARACTERISTICS, TREATMENTS AND TRANSPLANT FREQUENCY IN NEWLY-DIAGNOSED (NDMM) MULTIPLE MYELOMA

EHA Library, Sudeep Karve, 266523

REAL WORLD ASSESSMENT OF PRACTICE EFFICIENCY WITH THE INTRODUCTION OF SUBCUTANEOUS RITUXIMAB

EHA Library, Keith Dawson, 266524

TOLERABILITY OF TREATMENTS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW

EHA Library, Maria Nassim, 266525

DOES QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS DIFFER BETWEEN NATIONALITIES? A EUROPEAN MULTINATIONAL STUDY

EHA Library, Annemieke van Dongen - Leunis, 266526

COMPARISON OF ALLOPURINOL AND FEBUXOSTAT FOR PREVENTION OF HYPERURICEMIA AND TUMOR LYSIS SYNDROME IN ACUTE LEUKEMIAS

EHA Library, Sumeet Mirgh, 266527

LONG-TERM PROTEASOME INHIBITION (LTPI) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): US MM-6, A REAL-WORLD (RW) STUDY TRANSITIONING FROM BORTEZOMIB (BTZ) TO IXAZOMIB (IXA)

EHA Library, Robert M. Rifkin, 266528

CHRONIC RENAL FAILURE IN CHILDHOOD CANCER: AN INSIGHT FROM KIDS INPATIENT DATABASE

EHA Library, Eman M. Elsabbagh, 266529

A STRATEGY FOR THE MEASUREMENT OF SICKLE CELL DISEASE SYMPTOMS FROM THE PATIENT PERSPECTIVE

EHA Library, Funke Ojo, 266530

AN INDEPENDENT OBSERVATIONAL STUDY OF REAL LIFE COSTS OF CARE TO MYELOMA PATIENTS IN THE ERA OF NOVEL THERAPIES

EHA Library, Jane Thompson, 266531

COMBINED ORAL ANALGESIA AND ANXIOLYSIS FOR PAIN ASSOCIATED WITH BONE MARROW ASPIRATION AND BIOPSY.

EHA Library, Claudio Cerchione, 266532

PATIENT PREFERENCES FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS OF A PATIENT SURVEY OF RAVULIZUMAB (ALXN1210) AND ECULIZUMAB

EHA Library, Ioannis Tomazos, 266533

ECONOMIC MODEL TO EVALUATE THE COST-EFFECTIVENESS OF SECOND-LINE NILOTINIB VERSUS DASATINIB FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (CML-CP) IN GERMANY

EHA Library, Ricardo Viana, 266534

ZINC FINGER NUCLEASE-MEDIATED DISRUPTION OF THE BCL11A ERYTHROID ENHANCER IN PLERIXAFOR MOBILIZED CD34+ CELLS RESULTS IN ENRICHED BIALLELEIC EDITING AND ALLELE-ADDITIVE INCREASES IN FETAL HEMOGLOBIN

EHA Library, Pauline RIMMELE, 266535

SURVIVAL RATES AND CAUSES OF DEATH IN ELDERLY PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Valeria Maria Pinto, 266536

MORTALITY IN CHILDREN WITH SICKLE CELL DISEASE IN METROPOLITAN FRANCE FROM 2000 TO 2015

EHA Library, Valentine Brousse, 266537

SICKLE CELL DISEASE IN GERMANY IS HETEROGENEOUS AND RESULTS IN SEVERE MORBIDITY: ANALYSES FROM A NATIONAL REGISTRY

EHA Library, Andreas E. Kulozik, 266538

CEREBRAL BLOOD FLOW IN ADOLESCENTS WITH SICKLE CELL ANEMIA RECEIVING VOXELOTOR

EHA Library, Jeremie Estepp, 266539

PERIOPERATIVE CARE OF CHILDREN WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW AND CLINICAL RECOMMENDATIONS

EHA Library, Frédérica Schyrr, 266540

CEREBRAL OXYGEN METABOLISM MEASUREMENTS WITH MRI IN ADULTS WITH SICKLE CELL DISEASE

EHA Library, Lena Vaclavu, 266541

PENICILLIN PROPHYLAXIS AND PNEUMOCOCCAL VACCINE USE IN ADULT SICKLE CELL PATIENTS: A RETROSPECTIVE ANALYSIS OF CLINICAL PRACTICE AND OUTCOMES IN OXFORD, UK

EHA Library, Ayesha Ejaz, 266542

SPECTRUM OF PARVOVIRUS B19 INFECTION IN CHILDREN WITH SICKLE CELL DISEASE: ATYPICAL PRESENTATIONS.

EHA Library, Mohamed Elshinawy, 266543

HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANT FOR POEMS SYNDROME: EFFECTIVE, BUT HOW TO OPTIMISE?

EHA Library, Oliver Tomkins, 266544

IMPACT OF PRETRANSPLANTATION CYTOREDUNCTION STRATEGY AND PROGNOSTIC MUTATIONS IN ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASTIC-RELATED CHANGES

EHA Library, Feng-Ming Tien, 266545

DEFIBROTIDE TREATMENT IN ADULTS WITH SEVERE OR VERY SEVERE VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION: DEFIFRANCE STUDY INTERIM RESULTS

EHA Library, Ibrahim Yakoub-Agha, 266546

ENTEROCOCCUS-PREDOMINANT INTESTINAL MICROBIOTA INDICATES POOR PROGNOSIS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Shinsuke Kusakabe, 266547

A MACHINE-LEARNING APPROACH TO GRADE ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Amin Turki, 266548

SEVERE INFECTIONS IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS RECEIVING POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GVHD PROPHYLAXIS: HAPLOIDENTICAL VS MATCHED RELATED OR UNRELATED DONOR TRANSPLANTATION

EHA Library, Anna Bosch-Vilaseca, 266549

POST-TRANSPLANT CYCLOPHOSPHAMIDE AND SIROLIMUS IN HAPLOIDENTICAL TRANSPLANT WITH PBSC GRAFTS: RESULTS IN 151 PATIENTS

EHA Library, Margherita Silani, 266550

AUTOLOGOUS STEM CELL TRANSPLANT CONDITIONING WITH CHIDAMIDE, CLADRIBINE, GEMCITABINE AND BUSULFAN AS CONSOLIDATION MAY OVERCOME POOR PROGNOSIS OF PATIENTS WITH DOUBLE EXPRESSER LYMPHOMA

EHA Library, Jie Ji, 266551

IMPACT OF ANTI-THYMOCYTE GLOBULIN DOSES IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH MYELOID NEOPLASM

EHA Library, Jun Yeb Nam, 266552

PERMANENT IMPAIRMENT-FREE, RELAPSE-FREE SURVIVAL: A NOVEL COMPOSITE ENDPOINT TO EVALUATE LONG-TERM SUCCESS IN ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Yoshitaka Adachi, 266553

PD-1 PATHWAY IS A KEY IMMUNOSUPPRESSIVE MECHANISM IN PATIENTS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH TCR ΑΒ-DEPLETION.

EHA Library, Natalia Popova, 266554

DONOR UNC-93 HOMOLOG B1 GENETIC VARIATION PREDICTS SURVIVAL OUTCOMES AFTER UNRELATED BONE MARROW TRANSPLANTATION

EHA Library, Kaori Uchino, 266555

REDUCED INTENSITY CONDITIONING AND AVOIDING USE OF BROAD SPECTRUM ANTIBIOTHERAPY ACTIVE AGAINST GRAM-NEGATIVE BACTERIA MIGHT HAVE A CUMULATIVE IMPACT IN REDUCING INTESTINAL MICROBIOTA MISBALANCE.

EHA Library, Ildefonso Espigado, 266556

MULTI-CENTER, PHASE II STUDY ON HAPLOIDENTICAL BONE MARROW TRANSPLANTATION USING A RIC REGIMEN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PATIENTS WITH POOR PROGNOSIS LYMPHOMAS.

EHA Library, Luca Castagna, 266557

ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES FROM HLA IDENTICAL SIBLINGS OR HAPLOIDENTICAL DONORS: A COMPARISON.

EHA Library, Andrea Corbingi, 266558

DYSBIOSIS IN GUT MICROBIOTA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE DETERMINED BY THE COMBINATION OF CONDITIONING REGIMEN AND ANTIBIOTIC USAGE

EHA Library, Yasuyuki Arai, 266559

REDUCED INTENSITY CONDITIONING REGIMEN WITH ALEMTUZUMAB BASED T CELL DEPLETION ENABLES EARLY POST-TRANSPLANTATION CELLULAR INTERVENTION RESTORING GRAFT VERSUS LEUKEMIA EFFECTS IN OLDER AML PATIENTS.

EHA Library, Eva Koster, 266560

EFFECTS OF TWO DOSES OF ANTITHYMOCYTE GLOBULIN IN CONDITIONING REGIMENS FOR HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

EHA Library, Xiaosheng Fang, 266561

STEM CELL TRANSPLANTATION FOR MANTLE-CELL LYMPHOMA - A SINGLE CENTRE EXPERIENCE (2010-2018)

EHA Library, Telma Nascimento, 266562

PRETRANSPLANT INCREASING RATE OF LACTATE HYDROGENASE DURING TREATMENT FREE PERIOD PREDICTS TRANSPLANT OUTCOMES FOR PATIENTS WITH MYELOID HEMATOLOGICAL MALIGNANCIES NOT IN REMISSION

EHA Library, Takanobu Morishita, 266563

RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN PATIENTS ABOVE THE AGE OF 70 ARE COMPARABLE TO THE RESULTS IN YOUNGER PATIENTS

EHA Library, Kas Mamat, 266564

T CELL EXHAUSTION PROFILE (CD4+/CD28/PER+/GRA+ CD8+/CD28/PER+/GRA+) IN STEM CELL TRANSPLANTATION, CMV RE ACTIVATIONS AND RESPIRATORY VIRUS INFECTION.CELLULAR DYNAMICS IN THE FIRST 100 DAYS POST SCT

EHA Library, Miguel Villanueva, 266565

PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF ONE OR TWO DOSES OF DONOR LYMPHOCYTES DEPLETED OF HOST ALLOREACTIVE T-CELLS (ATIR101) FOLLOWING T-CELL-DEPLETED HAPLOIDENTICAL HSCT

EHA Library, Eduardo Olavarria, 266566